Trillion-dollar partner: Recursion raises $50M from Nvidia, stock skyrockets
Recursion Pharmaceuticals raised $50 million from Nvidia via a PIPE that placed the AI biotech squarely into the investor fervor surrounding the tech company.
Recursion said Wednesday morning it now plans to work with Nvidia on the software company’s cloud service that uses generative AI for drug discovery. Recursion brings a massive biochemical dataset through which Nvidia’s drug discovery foundation models can be trained.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.